FOXP3 and neoplasm: Fifteen days after tumor challenge, the frequency of Foxp3-GFP+ cells in the tumor draining lymph node (TDLN) and spleen of treated and untreated animals was analyzed by fluorescence-activated cell sorting (FACS).